Medical News Today
Small Molecule Compound Being Studied For The Treatment Of Relapsing-Remitting Multiple Sclerosis
05 Oct 2006
UCB (Euronext Brussels: UCB) and Biogen Idec ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Wednesday, November 21
study for oral treatment of RRMS
by
All About MS
on Wed 21 Nov 2007 11:09 AM CST
|
||